Quantcast

Latest Novartis Stories

2014-06-13 12:22:37

NEW YORK, June 13, 2014 /PRNewswire/ -- PHARMACEUTICAL EXECUTIVE magazine's June cover ranks Pharma's 50 top global pharmaceutical companies by revenues. PHARMACEUTICAL EXECUTIVE'S June issue features the annual review of the top 50 biopharmaceutical companies in industry sales--a standard benchmark of success that has remained surprisingly static since the magazine has began ranking the 50 largest players back in the April 2000 issue. Over these 14 years, just three...

2014-06-13 08:24:31

SCRS Welcomes INC Research, inVentiv Health, Novartis and Sanofi ELLICOTT CITY, Md., June 13, 2014 /PRNewswire/ -- Leading sponsor and CRO organizations continue to join the Society for Clinical Research Sites' (SCRS) Global Impact Partner (GIP) program at a rapid pace. Since April 1, INC Research, inVentiv Health, Novartis and Sanofi have joined the SCRS GIP program. From its inception only one year ago, the initiative has quickly grown to 25 leading organizations. Global Impact...

2014-06-13 08:23:37

DALLAS, June 13, 2014 /PRNewswire/ -- MarketReportsChina.com adds "Research on China Cardiovascular Drugs Industry, 2014-2018" market intelligence report of 85 pages to its store. Delivery of this report will take 24 hours post purchase. Research on China Cardiovascular Drugs Industry, 2014-2018 says in the next ten years, there is a potential for the growth in cardiovascular diseases treatment field. It is predicted that the growth rate will be of more than 20% from...

2014-06-10 08:31:46

- Veteran of animal health brings depth of expertise to Merial's R&D organization - LYON, France, June 10, 2014 /PRNewswire/ -- Merial, the animal health division of Sanofi, today announced that Fabian Kausche will be leading the company's global research and development (R&D) efforts, effective June 9, 2014. Dr. Kausche brings to the company a wide range of global experience in pharmaceutical and biological R&D and business leadership positions, at both human and animal...

2014-06-04 08:34:06

LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Hepatitis Drugs and Vaccines: World Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/therapeutic/hepatitis_drugs_vaccines_world_market_2013_2023.html Report DetailsYour guide to sales outlooks and R&D for hepatitis treatmentsWhere are hepatitis medicines going? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and...

2014-06-03 12:31:25

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:World OTC Pharmaceutical Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/world_otc_pharmaceutical_market_2012_2022.html Report DetailsDiscover the highest potential revenues in over-the-counter medicineWhat does the future hold for OTC medicines? Visiongain's report shows you potential revenues to 2023, assessing data, trends, opportunities and...

2014-06-02 12:29:47

Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Advancing BOULDER, Colo., June 2, 2014 /PRNewswire/ -- Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and selumetinib, were showcased at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). At the meeting, preliminary data for the combination of binimetinib and CDK4/6 inhibitor LEE011 (discovered by Novartis Institutes for BioMedical Research in collaboration with Astex...

2014-06-02 08:32:06

Results show adding LBH589 to bortezomib and dexamethasone significantly improved PFS by 37%, meeting Phase III study primary endpoint1 EAST HANOVER, N.J., June 2, 2014 /PRNewswire/ -- Novartis today presented results from a pivotal Phase III trial showing a 37% improvement in progression-free survival (PFS) when using the investigational compound LBH589 (panobinostat) in combination with bortezomib[*] and dexamethasone compared to treatment with the same regimen with placebo in patients with...

2014-05-27 23:04:17

AgFunder, an online investment crowdfunding platform for agriculture and agtech opportunities, is hosting a webinar for accredited investors interested in aWhere, a cloud-based service delivering hyperlocal weather data and recommendations to farmers around the globe. New York, NY (PRWEB) May 27, 2014 aWhere will be raising a $4 million equity financing round on the investment crowdfunding platform AgFunder. aWhere is a Colorado-based agtech company delivering hyperlocal weather data and...

2014-05-27 12:23:12

- Contest runs through July for innovative ideas to support the six commitments of The Good Growth Plan WASHINGTON, May 27, 2014 /PRNewswire/ -- Syngenta announced today a contest for creative ideas that will support one or more of the six measurable commitments of The Good Growth Plan. The Good Growth Plan Grant Contest* will award one Grand Prize of $20,000 to help the winner implement the idea. Also, three runners-up will receive $10,000 each for the same purpose. Deadline for submissions...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related